Generally all normal respondents would be expected to pass the subtest by scoring the maximum.
By comparison, the control B1 peptide had only auxiliary residues to be presented by the A*0201 molecule and scores a maximum of 12.
Agreement was therefore informally assessed by scoring 1 pig, scanned the maximum possible 8 times, on 2 occasions with a time gap of 1 week.
A total score for each paper was determined by summing the five characteristic scores, giving a maximum possible score of 15.
A total overall score was calculated by adding the above scores, with a maximum of 12 points possible.
Similarly, clinical efficacy for the total cohort, determined by clinical outcome scores, reached a maximum at 24 months without decline to 60 months.
In the event of discordant scores, which differed by a maximum of 1 point, the mean of the two scores was used.
This assessment procedure was applied prior to the actual commencement of the study protocol, aiming to provide the attending physician with the structured information in the following categories: standard anthropometric measurements, inclusive of BMI (to screen out any possible nutritional deficit), global evaluation and dietetic assessment, expressed by a maximum score of 30 points.
Based on 6 key criteria (matching of subjects and controls, power calculation justifying sample size, reproducibility of electrode position - this could include a reference for further details, reliability of EMG equipment, tester blind to group allocation, and sufficient results in the text or supplied by the authors) a maximum score of 6 was awarded to each study.
Raw subscale scores for anxiety and depression are calculated by adding all item scores together for a maximum possible score of 21.
